Get the Stockscreener App
0.5402
4.32%
-0.0244
Pre-market:
.55
0.0098
+1.81%
Nexgel Inc stock is traded at $0.5402, with a volume of 168.30K.
It is down -4.32% in the last 24 hours and down -3.62% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.5646
Open:
$0.541
24h Volume:
168.30K
Relative Volume:
0.58
Market Cap:
$4.98M
Revenue:
$11.26M
Net Income/Loss:
$-3.09M
P/E Ratio:
-1.3475
EPS:
-0.4009
Net Cash Flow:
$-1.49M
1W Performance:
+3.45%
1M Performance:
-3.62%
6M Performance:
-69.31%
1Y Performance:
-79.62%
1-Day Range:
$0.5314
$0.5691
1-Week Range:
$0.50
$0.5845
52-Week Range:
$0.4794
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.5402 | 4.62M | 11.26M | -3.09M | -1.49M | -0.4009 |
ISRG
Intuitive Surgical Inc
|
432.83 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.54 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.75 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
68.33 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.40 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Nexgel Inc Stock (NXGL) Latest News
NexGel, Inc Warrant 2021-01.12.26 on NexGel Financial Disclosures & SEC Filings - TradingView
NexGel, Inc. Actuals & Estimates (NASDAQ:NXGL) - TradingView
NXGL Forecast — Price Target — Prediction for 2027 - TradingView
Nexgel Inc (NXGLW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 4 Nexgel Inc For: 23 June By Investing.com - Investing.com Nigeria
Nexgel CEO Adam R. Levy sells $6,519 in company stock - Investing.com
Nexgel CEO Adam R. Levy sells $6,519 in company stock By Investing.com - Investing.com Canada
Insider sale: NEXGEL (NXGL) CEO sells 11,000 common shares - Stock Titan
Nexgel Inc (NXGLW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexgel Inc (NXGLW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexgel Inc (NXGLW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexgel Inc (NXGLW) Institutional Confidence - TradingKey
Nexgel Inc (NXGLW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Number of shareholders of NexGel, Inc – NASDAQ:NXGLW - TradingView
NexGel Updates Investor Presentation Under Regulation FD Disclosure - TipRanks
Nexgel Inc (NXGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexgel Inc (NXGL) Institutional Confidence - TradingKey
NXGL: Expanded regenerative medicine portfolio and direct sales force set stage for rapid growth - TradingView
Nexgel Inc (NXGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexgel Inc (NXGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexgel Inc (NXGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexgel Inc (NXGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NexGel begins using new investor presentation under Regulation FD - TradingView
NexGel (NASDAQ: NXGL) furnishes updated investor presentation under Reg FD - Stock Titan
Nexgel Inc (NXGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nexgel Inc (NXGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexgel Inc (NXGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nexgel Inc (NXGLW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nexgel Inc (NXGLW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nexgel Inc (NXGLW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexgel CEO Adam Levy sells $1,840 in shares By Investing.com - Investing.com India
Nexgel CEO Adam Levy sells $1,840 in shares - Investing.com
NEXGEL (NXGL) CEO sells 3,000 shares, retains 333,692-holding stake - Stock Titan
Nexgel CEO Adam Levy sells $3,421 of common stock By Investing.com - Investing.com Nigeria
Nexgel CEO Adam Levy sells $3,421 of common stock - Investing.com
NEXGEL (NXGL) CEO Adam Levy sells 6,000 common shares but keeps large stake - Stock Titan
Large potential dilution as NexGel (NASDAQ: NXGL) seeks note conversion, Nevada move and reverse split - Stock Titan
NEXGEL Expands Investor Outreach With MicroCap Conference Appearance - MyChesCo
NXGL Q1 2026 Earnings: EPS Misses Estimates by 54% Despite Positive Stock ReactionProfitability Analysis - newsline.com
NexGel Inc Warrant (NXGLW) Slides Marginally, Testing Key Support at $0.04Volume Nodes - newsline.com
NexGel stock (US65340W1027): Micro-cap hydrogel specialist in focus after recent volatility - Ad-hoc-news.de
NexGel Inc (NXGL) Weakens by 4.43% as Shares Approach Critical $0.53 Support LevelNHNL Divergence - newsline.com
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th -18th - The Manila Times
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th - GlobeNewswire
NEXGEL heads to Las Vegas for Planet MicroCap 2026 conference - Stock Titan
Nexgel CEO Adam Levy sells $1,171 in company stock - Investing.com UK
Nexgel CEO Adam Levy sells $1,171 in company stock By Investing.com - Investing.com Australia
NXGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NEXGEL (NXGL) CEO Adam R. Levy sells 2,000 common shares at $0.5859 - Stock Titan
New Celularity (NASDAQ: CELU) CCO to drive cenplacel-L and Lifebank growth - Stock Titan
Celularity outlines placenta cell therapy push to extend health span - Stock Titan
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nexgel Inc Stock (NXGL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer |
Jun 23 '26 |
Sale |
0.59 |
5,000 |
2,967 |
322,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 11 '26 |
Sale |
0.61 |
3,000 |
1,841 |
333,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 04 '26 |
Sale |
0.59 |
3,000 |
1,781 |
339,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 08 '26 |
Sale |
0.55 |
3,000 |
1,641 |
336,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 01 '26 |
Sale |
0.59 |
2,000 |
1,172 |
342,692 |
| Levy Adam R. | Chief Executive Officer |
May 28 '26 |
Sale |
0.61 |
7,000 |
4,241 |
347,692 |
| Levy Adam R. | Chief Executive Officer |
May 29 '26 |
Sale |
0.60 |
3,000 |
1,801 |
344,692 |
| Levy Adam R. | Chief Executive Officer |
May 27 '26 |
Sale |
0.60 |
3,000 |
1,792 |
354,692 |
0.31%
2.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):